Corrigendum: Comparing and Combining Topiramate and Aripiprazole on Alcohol-Related Outcomes in a Human Laboratory Study

Corrigendum: Comparing and Combining Topiramate and Aripiprazole on Alcohol-Related Outcomes in a... Alcohol and Alcoholism, 2018, 53(4) 500 doi: 10.1093/alcalc/agy030 Advance Access Publication Date: 27 April 2018 Corrigendum: Comparing and Combining Topiramate and Aripiprazole on Alcohol-Related Outcomes in a Human Laboratory Study 1,2,3, 2,3 1 2,3 Carolina L. Haass-Koffler , Kimberly Goodyear , William H. Zywiak , Lorenzo Leggio , 1 1,4 George A. Kenna , and Robert M. Swift Center for Alcohol and Addiction Studies, Department of Psychiatry and Human Behavior, Brown University, Providence, RI, USA, Center for Alcohol and Addiction Studies, Department of Behavioral and Social Sciences, Brown University, Providence, RI, USA, Section on Clinical Psychoneuroendocrinology and Neuropsychopharmacology, National Institute on Alcohol Abuse and Alcoholism; and National Institute on Drug Abuse, National Institutes of Health, Bethesda, MD, USA, and Veterans Affairs Medical Center, Providence, RI, USA *Corresponding author: Center for Alcohol and Addiction Studies, Department Psychiatry and Human Behavior, Brown University, 121 South Main Street, Providence, RI 02912, USA. Tel: 401-863-6624; Fax: 401-863-6647; E-mail: carolina_haass-koffler@brown.edu Alcohol and Alcoholism, 2015, 50(4): 458–462, doi: 10.1093/alcalc/agx108 In our manuscript (Haass-Koffler et al., 2017), we report that after collapsed. Of note, the reduction of BMI by 0.36 (0.16), which is 4 week titration and 1 week at target dose, there was a significant ~1 kg for an average person, would not affect amount of alcohol main effect for topiramate in decreasing body mass index (BMI). consumed in the laboratory (priming drink) since it would have However, we did not specify how much BMIs declined. This infor- influenced minimally the calculation of the alcohol to be adminis- mation is important to report as the amount of the self-administered tered as standard unit drink. For example, in a 45-year-old male, alcohol was adjusted based on body water during the human weight 80 Kg, height 1.75 m (BMI = 26.1), according to the Watson laboratory phase and the calculation is in part based on body equation (Watson et al., 1981), the calculated amount of alcohol in weight. This information could be relevant to the study findings that the priming dose correspond to 16.6 g. For the same male, the topiramate 200 mg/day reduced alcohol consumption and lessened reduction of BMI by 0.36 (BMI = 25.8), the amount of alcohol in alcohol craving in the naturalistic phase, but not in the human the priming dose would correspond to 16.4 g (0.2 g difference). laboratory phase. At Week 5, there was a significant main effect for topiramate on BMI [F = 6.07, P = 0.019] with aripiprazole as covariate and 1,37 REFERENCES interaction with time, see manuscript for statistical approach Haass-Koffler CL, Goodyear K, Zywiak WH, et al. (2017) Comparing and (Haass-Koffler et al., 2017). The topiramate group showed a mean combining topiramate and aripiprazole on alcohol-related outcomes in a BMI loss of 0.36 (0.16 SD) while groups not receiving topiramate human laboratory study. Alcohol Alcohol. (aripiprazole and placebo) showed a mean BMI gain of 0.32 (0.22 Watson PE, Watson ID, Batt RD. (1981) Prediction of blood alcohol concen- SD) from baseline. The significant reduction of BMI, was observed trations in human subjects. Updating the Widmark Equation. J Stud only when the topiramate doses (100 mg and 200 mg) were Alcohol 42:547–56. Downloaded from https://academic.oup.com/alcalc/article-abstract/53/4/500/4989376 by Ed 'DeepDyve' Gillespie user on 26 June 2018 http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Alcohol and Alcoholism Oxford University Press

Corrigendum: Comparing and Combining Topiramate and Aripiprazole on Alcohol-Related Outcomes in a Human Laboratory Study

Free
1 page

Loading next page...
1 Page
 
/lp/ou_press/corrigendum-comparing-and-combining-topiramate-and-aripiprazole-on-br0tOP200S
Publisher
Oxford University Press
Copyright
© The Author(s) 2018. Medical Council on Alcohol and Oxford University Press. All rights reserved.
ISSN
0735-0414
eISSN
1464-3502
D.O.I.
10.1093/alcalc/agy030
Publisher site
See Article on Publisher Site

Abstract

Alcohol and Alcoholism, 2018, 53(4) 500 doi: 10.1093/alcalc/agy030 Advance Access Publication Date: 27 April 2018 Corrigendum: Comparing and Combining Topiramate and Aripiprazole on Alcohol-Related Outcomes in a Human Laboratory Study 1,2,3, 2,3 1 2,3 Carolina L. Haass-Koffler , Kimberly Goodyear , William H. Zywiak , Lorenzo Leggio , 1 1,4 George A. Kenna , and Robert M. Swift Center for Alcohol and Addiction Studies, Department of Psychiatry and Human Behavior, Brown University, Providence, RI, USA, Center for Alcohol and Addiction Studies, Department of Behavioral and Social Sciences, Brown University, Providence, RI, USA, Section on Clinical Psychoneuroendocrinology and Neuropsychopharmacology, National Institute on Alcohol Abuse and Alcoholism; and National Institute on Drug Abuse, National Institutes of Health, Bethesda, MD, USA, and Veterans Affairs Medical Center, Providence, RI, USA *Corresponding author: Center for Alcohol and Addiction Studies, Department Psychiatry and Human Behavior, Brown University, 121 South Main Street, Providence, RI 02912, USA. Tel: 401-863-6624; Fax: 401-863-6647; E-mail: carolina_haass-koffler@brown.edu Alcohol and Alcoholism, 2015, 50(4): 458–462, doi: 10.1093/alcalc/agx108 In our manuscript (Haass-Koffler et al., 2017), we report that after collapsed. Of note, the reduction of BMI by 0.36 (0.16), which is 4 week titration and 1 week at target dose, there was a significant ~1 kg for an average person, would not affect amount of alcohol main effect for topiramate in decreasing body mass index (BMI). consumed in the laboratory (priming drink) since it would have However, we did not specify how much BMIs declined. This infor- influenced minimally the calculation of the alcohol to be adminis- mation is important to report as the amount of the self-administered tered as standard unit drink. For example, in a 45-year-old male, alcohol was adjusted based on body water during the human weight 80 Kg, height 1.75 m (BMI = 26.1), according to the Watson laboratory phase and the calculation is in part based on body equation (Watson et al., 1981), the calculated amount of alcohol in weight. This information could be relevant to the study findings that the priming dose correspond to 16.6 g. For the same male, the topiramate 200 mg/day reduced alcohol consumption and lessened reduction of BMI by 0.36 (BMI = 25.8), the amount of alcohol in alcohol craving in the naturalistic phase, but not in the human the priming dose would correspond to 16.4 g (0.2 g difference). laboratory phase. At Week 5, there was a significant main effect for topiramate on BMI [F = 6.07, P = 0.019] with aripiprazole as covariate and 1,37 REFERENCES interaction with time, see manuscript for statistical approach Haass-Koffler CL, Goodyear K, Zywiak WH, et al. (2017) Comparing and (Haass-Koffler et al., 2017). The topiramate group showed a mean combining topiramate and aripiprazole on alcohol-related outcomes in a BMI loss of 0.36 (0.16 SD) while groups not receiving topiramate human laboratory study. Alcohol Alcohol. (aripiprazole and placebo) showed a mean BMI gain of 0.32 (0.22 Watson PE, Watson ID, Batt RD. (1981) Prediction of blood alcohol concen- SD) from baseline. The significant reduction of BMI, was observed trations in human subjects. Updating the Widmark Equation. J Stud only when the topiramate doses (100 mg and 200 mg) were Alcohol 42:547–56. Downloaded from https://academic.oup.com/alcalc/article-abstract/53/4/500/4989376 by Ed 'DeepDyve' Gillespie user on 26 June 2018

Journal

Alcohol and AlcoholismOxford University Press

Published: Apr 27, 2018

There are no references for this article.

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off